Ignite Creation Date:
2024-05-06 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 2:14 PM
Study NCT ID:
NCT05055232
Status:
UNKNOWN
Last Update Posted:
2021-09-24
First Post:
2021-09-14
Brief Title:
A Phase I Study of XZP-3621 in Chinese Patients With ALK or ROS1 Rearrangement Non-small Cell Lung Cancer
Sponsor:
Xuanzhu Biopharmaceutical Co Ltd
Organization:
Xuanzhu Biopharmaceutical Co Ltd
Organization Data
Organization:
Xuanzhu Biopharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
XZP-3621-1001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xuanzhu Biopharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None